Skip to content

Clinical trials

Phase 3 Staphylococcal Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Staphylococcal Infections Phase: Phase 3 Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20043
20056
20074
20082
20111
20131
20141
20181
20191
20221
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nabi Biopharmaceuticals7
Cumberland Pharmaceuticals3
Aridis Pharmaceuticals, Inc.2
Forest Laboratories2
Assistance Publique - Hôpitaux de Paris1
Basilea Pharmaceutica1
Clinical Research Centre, Malaysia1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Heinrich-Heine University, Duesseldorf1
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Staphylococcal Infections28
Bacteremia4
Bacterial Infections4
Staphylococcal Skin Infections4
Surgical Wound Infection4
Cellulitis3
Infections3
Kidney Failure, Chronic3
Pneumonia, Ventilator-Associated3
Sepsis3

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.